LATTANZI, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 3.692
EU - Europa 1.247
AS - Asia 697
SA - Sud America 51
AF - Africa 28
OC - Oceania 5
Totale 5.720
Nazione #
US - Stati Uniti d'America 3.633
IT - Italia 522
SG - Singapore 314
IN - India 183
SE - Svezia 172
CN - Cina 134
UA - Ucraina 113
FI - Finlandia 98
DE - Germania 68
AT - Austria 58
CA - Canada 55
IE - Irlanda 49
BG - Bulgaria 43
AR - Argentina 40
GB - Regno Unito 40
ID - Indonesia 35
FR - Francia 30
RU - Federazione Russa 16
TG - Togo 14
JP - Giappone 12
RO - Romania 9
BE - Belgio 8
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
BR - Brasile 5
CL - Cile 5
IR - Iran 4
KR - Corea 4
NG - Nigeria 4
NL - Olanda 4
NZ - Nuova Zelanda 4
TR - Turchia 4
MX - Messico 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
ES - Italia 2
ZA - Sudafrica 2
AU - Australia 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
LK - Sri Lanka 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
Totale 5.720
Città #
Fairfield 549
Chandler 366
Woodbridge 289
Rome 281
Ashburn 250
Singapore 239
Seattle 197
Houston 193
Ann Arbor 178
Cambridge 174
Wilmington 165
Beijing 106
Princeton 102
Plano 83
San Paolo di Civitate 76
Boston 69
Lawrence 68
Santa Clara 65
Vienna 53
New York 44
San Diego 43
Sofia 43
Menlo Park 42
Federal 39
Bremen 37
Millbury 37
Boardman 34
Dublin 34
Jakarta 34
Jacksonville 33
Andover 26
Ottawa 24
Norwalk 20
Falls Church 19
Helsinki 16
Dearborn 14
Lomé 14
Toronto 14
Paris 13
London 11
Milan 11
Moscow 11
Falkenstein 9
Gatineau 9
Des Moines 8
Brussels 7
Fremont 7
Phoenix 7
Abidjan 6
San Mateo 6
Bühl 5
Hefei 5
Indiana 5
Lappeenranta 5
Mississauga 5
Santiago 5
Kunming 4
Latina 4
Mannheim 4
Oxford 4
Auckland 3
Dallas 3
Devinska Nova Ves 3
Fuzhou 3
Hwaseong-si 3
Istanbul 3
Kashiwa 3
Lahore 3
Legnano 3
Los Angeles 3
L’Aquila 3
Maddaloni 3
Mexico City 3
Padova 3
Redmond 3
Redwood City 3
Rio de Janeiro 3
San Francisco 3
Teramo 3
Tokyo 3
Washington 3
Barcelona 2
Bonate Sopra 2
Brescia 2
Bridgeville 2
Brindisi 2
Chicago 2
Dobbs Ferry 2
Fort Worth 2
Frankfurt am Main 2
Genoa 2
Giussano 2
Guangzhou 2
Hounslow 2
Hyderabad 2
Jesi 2
Las Vegas 2
Monmouth Junction 2
Montréal 2
Muizenberg 2
Totale 4.322
Nome #
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 18,19-DEHYDROBUPRENORPHINE 122
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 119
Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8 110
N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans. 99
Chemokines in alzheimer’s disease: new insights into prokineticins, chemokine-like proteins 95
Expression of Bv8 in pichia pastoris to identify structural features for receptor binding 94
Identification and characterization of prokineticin receptor 2 splicing variant and its modulation in an animal model of alzheimer's disease 94
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 90
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 88
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 88
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 87
G-CSF related bone pain (BP) and Bv8/PK2 expression: Is there a link in breast cancer (BC) patients (pts) treated with FEC100 adjuvant chemotherapy (CT)? 87
Bv8-Prokineticins and their Receptors: Modulators of Pain 86
HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 84
Biological activities of Bv8 analogues 83
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor 81
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals. 80
A palmitoylethanolamide producing lactobacillus paracasei improves clostridium difficile toxin a-induced colitis 79
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 78
Conformationally constrained opioid ligands: The Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold 76
Analogues of both Leu- and Met-enkephalin containing a constrained dipeptide isostere prepared from a Baylis-Hillman adduct 76
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: Focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior 74
Bv8, the amphibian homologue of the mammalian prokineticins, modulates ingestive behaviour in rats 73
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 73
Nociceptive sensitization by the secretory protein Bv8. 71
Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem. 70
Bv8/Prokineticin proteins and their receptors 68
The prokineticin Bv8 sensitizes cutaneous terminals of female mice to heat 68
The balance of concentration between Prokineticin 2β and Prokineticin 2 modulates the food intake by STAT3 signaling 68
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 67
Antinociceptive activity of a novel buprenorphine analogue 67
Effects of the intravenous administration of [Lys7]dermorphin on local cerebral glucose utilization in the rat. 65
In vitro and in vivo pharmacological activities of 14-o-phenylpropyloxymorphone, a potent mixed mu/delta/kappa-opioid receptor agonist with reduced constipation in mice 65
Age-related ultrastructural and monoamine oxidase changes in the rat optic nerve 65
Pharmacology of amphibian opiate peptides 62
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 61
Pharmacological activity of a Bv8 analogue modified in position 24 61
A Progressive build-up of perineuronal nets in the Somatosensory Cortex Is Associated with the Development of Chronic Pain in Mice 60
Identification and characterization of a new splicing variant of prokineticin 2 59
A New Convenient Synthetic Method and Preliminary Pharmacological Characterization of Triazinediones as Prokineticin Receptor Antagonists 58
Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration 58
The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflex in the rat. 57
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 57
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors 57
Novel glycosylated (LyS(7))-dermorphin analogues: synthesis, biological activity and conformational investigations 57
Novel nociceptin analogues: Synthesis and biological activity 56
The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1 56
Modulators of Pain: Bv8 and Prokineticins 55
Prokineticin Receptor 1 Antagonist PC-10 as a Biomarker for Imaging Inflammatory Pain 55
Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats 55
Triazine Compounds as Antagonists at Bv8-Prokineticin Receptors 54
Critical role for prokineticin 2 in CNS autoimmunity 54
Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system 53
6-N,N-Dimethylamino-2,3-Naphthalimide a New Environment-Sensitive Fluorescent Probe in delta-Selective and mu-Selective Opioid Peptides 53
Serum substance P is increased in Parkinson's disease and correlates with motor impairment 53
New 2 ',6 '-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands 52
Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of the mu-, delta-, kappa- opioid receptor knockout mice. 51
Analysis of role of aromatic residues in extracellular loop 2 of Prokineticin receptor 2 in ligand binding probed with genetically encoded photo-crosslinkers 51
The multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain 50
Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 22. Influence of the 14-Alkoxy Group and the Substitution in Position 5 in 14-Alkoxymorphinian-6-ones on in Vitro and in Vivo Activities 49
A new opioid designed multiple ligand derived from the mu opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic 49
Antinociceptive effects and mechanism of opioid activity of [Lys7]dermorphin, a naturally occurring peptide with high affinity and selectivity for mu-opioid receptors 49
Opioid peptides: Synthesis and biological activity of new endomorphin analogues 49
Involvement of the chemokine prokineticin-2 (PROK2) in Alzheimer's disease: from animal models to the human pathology 49
Identification of regions involved in the physical interaction between melanocortin receptor accessory protein 2 and prokineticin receptor 2 48
Serum prokineticin-2 in prepubertal and adult Klinefelter individuals 47
Bv8, a small protein from frog skin induces antidiuresis in rats 46
Abnormal pain sensation in mice lacking the prokineticin receptor PKR2: interaction of PKR2 with transient receptor potential TRPV1 and TRPA1 46
Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors. 45
Bv8/Prokineticins and their Receptors A New Pronociceptive System. 44
Dermorphin and deltorphin glycosilated analogs: synthesis and antinociceptive activity after systemic administration 43
Highly Selective Fluorescent Analogue of the Potent delta-Opioid Receptor Antagonist Dmt-Tic 43
Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys 7]dermorphin in awake rat 41
A new buprenorphine analog with potent antinociceptive activity never induced place preference in rats. 41
The role of prokineticin 2 in oxidative stress and in neuropathological processes 41
Prokineticin-receptor network: mechanisms of regulation 41
HS-599: a novel long acting opioid analgesic does not induce place-prefence in rats 39
Cardiovascular responses to the mu-opioid agonist [Lys7]dermorphin in rats 38
Trypanosoma cruzi trans-sialidase induces STAT3 and ERK activation by prokineticin receptor 2 binding 38
HALOGENATED TRIAZINEDIONES BEHAVE AS ANTAGONISTS OF PKR1: IN-VITRO ANDIN-VIVO PHARMACOLOGICAL CHARACTERIZATION 36
PHARMACOLOGY OF BV8, A NEW PEPTIDE FROM AMPHIBIAN SKIN 35
Knockdown of rat brain δ-opioid receptors by antisense oligodeoxynucleotides 35
Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. 33
HALOGENATED TRIAZINEDIONES BEHAVE AS ANTAGONISTS OF PKR1: IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION 33
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 31
Effects of antisense oligodeoxynucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats. 31
Postnatal development of delta-opioid receptor subtypes in mice 30
Reduced expression of secretogranin VGF in laryngeal squamous cell carcinoma 29
INTERACTION BETWEEN THE MU-AGONIST DERMORPHIN AND THE DELTA-AGONIST [D-ALA(2), GLU(4)]DELTORPHIN IN SUPRASPINAL ANTINOCICEPTION AND DELTA-OPIOID RECEPTOR-BINDING 29
Increase of Prokineticin-2 in Serum of Patients with Parkinson's Disease 28
Olfactory neuron substance P is overexpressed in Parkinson's disease reflecting gut dysfunction 28
The novel peptide Bv8 regulates fluid intake in rats 27
Versatile role of prokineticins and prokineticin receptors in neuroinflammation 27
Olfactory neuron prokineticin-2 as a potential target in Parkinson's disease 25
Arginine 125 is an essential residue for the function of MRAP2 24
Non opioid motor effects of deltorphin analogs 24
Prokineticin 2 in cancer-related inflammation 23
MRAP2 inhibits β-arrestin-2 recruitment to the Prokineticin 2 receptor 2 23
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases 22
Opioid and Bv8 Peptides 22
Totale 5.666
Categoria #
all - tutte 21.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020692 0 0 0 0 0 109 128 119 106 79 114 37
2020/2021475 46 82 36 34 4 32 2 29 78 79 41 12
2021/20221.079 15 62 96 21 130 47 36 101 116 88 159 208
2022/20231.353 211 262 119 132 150 130 11 104 98 18 79 39
2023/2024619 52 94 39 49 36 96 20 34 8 69 51 71
2024/2025556 77 106 103 107 86 77 0 0 0 0 0 0
Totale 6.015